Wax, Emulsifying

drug
On this page

Also known as BuffCoconut oilunhydrogenatedEmulfinEmulsifEmulsifying waxEpadermH.e.b.Lanette waxLanette wax sxOilcoconutcocntWaxemulsifying

Summary

Wax, Emulsifying (CHEMBL2108813) is a phase-3 clinical-stage unknown; indicated across 7 conditions including autism spectrum disorder and severe acute respiratory syndrome.

At a glance

  • Status: Max clinical phase 3 (not approved)
  • Modality: Unknown
  • Indications: 7 conditions
  • Clinical trials: 31

Identifiers

Drug identity and classification

FieldValue
ChEMBL IDCHEMBL2108813
NameWax, Emulsifying
TypeUnknown
Max phase3

Also known as: Buff, Coconut oil, unhydrogenated, Emulfin, Emulsif, Emulsifying wax, Epaderm, H.e.b., Lanette wax, Lanette wax sx, Oil, coconut

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

7 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

IndicationTrial phaseMONDOEFO
autism spectrum disorder2MONDO:0005258EFO:0003756
severe acute respiratory syndrome2MONDO:0005091MONDO:0100096
stomatitis2MONDO:0004842EFO:1001904
Alzheimer disease2MONDO:0004975MONDO:0004975
leprosy1MONDO:0005124EFO:0001054
interstitial cystitis1MONDO:0018301EFO:0008507
multiple sclerosis1MONDO:0005301MONDO:0005301

Clinical trials

Total trials: 31.

Phase distribution

PhaseTrials
Not specified25
EARLY_PHASE12
PHASE41
PHASE21
PHASE1/PHASE21
PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07100145PHASE4NOT_YET_RECRUITINGEfficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus
NCT04845217PHASE1/PHASE2RECRUITINGPeppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
NCT03740295PHASE2COMPLETEDImpact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis
NCT01381354PHASE1COMPLETEDNutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)
NCT03185169EARLY_PHASE1TERMINATEDGSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
NCT07175090EARLY_PHASE1COMPLETEDEvaluation of Coconut Oil Mouth Rinse on Periodontal Parameters
NCT06818370Not specifiedRECRUITINGThe Effect of Coconut Oil on Alopecia
NCT07493434Not specifiedENROLLING_BY_INVITATIONEvaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial
NCT07550023Not specifiedRECRUITINGEffects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults
NCT00941837Not specifiedCOMPLETEDEffect of Dietary Fat Type in Combination With High Protein on Plasma Homocysteine Levels
NCT01250275Not specifiedCOMPLETEDEffects of Canola Oil on Blood Vessel Function in Peripheral Arterial Disease
NCT01876394Not specifiedUNKNOWNComparison of Dietary Fats on Vascular Parameters
NCT01962844Not specifiedUNKNOWNCoconut Oil in Cardiovascular Disease
NCT02679222Not specifiedCOMPLETEDComparing the Ketogenic Effect of Coconut Oil and Different MCTs
NCT02809235Not specifiedWITHDRAWNFatty Acids in Airway Smooth Muscle of Asthmatics
NCT03105947Not specifiedCOMPLETEDTrial of Different Dietary Fats on Blood Lipids and Metabolic Measures in Healthy Participants
NCT03176368Not specifiedUNKNOWNCoconut Oil: Managing Radiation-Induced Xerostomia
NCT03202654Not specifiedCOMPLETEDEffects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation
NCT03401281Not specifiedUNKNOWNTrial of Different Dietary Fat Sources on Blood Lipids and Other CVD Risk Factors
NCT03727386Not specifiedCOMPLETEDThe Effect of Vegetable Oil on Cognitive Functions of MCI Patients
NCT03738163Not specifiedCOMPLETEDA Clinical Investigation With Epaderm® Cream
NCT03904433Not specifiedCOMPLETEDQuantification of Ketosis After Intake of Coconut Oil and Caprylic Acid-With and Without Glucose-After a 12-hour Fast
NCT04245332Not specifiedSUSPENDEDEffects of Fish Oil and Resistance Training on Muscle Mass and Function
NCT04842786Not specifiedUNKNOWNTopical Coconut Oil Application and Incidence of Sepsis in Neonates
NCT05264233Not specifiedCOMPLETEDThe Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men
NCT05539742Not specifiedCOMPLETEDComparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia
NCT05653362Not specifiedCOMPLETEDCoconut Oil vs. Commercial Ultrasound Gel In Obstetric Ultrasounds
NCT05849571Not specifiedCOMPLETEDInvestigation of the Effect of Oral Care With Coconut Oil on the Degree of Oral Mucositis in Pediatric Oncology Patients
NCT06049589Not specifiedCOMPLETEDTherapeutic Application of Coconut Oil in Oral Health
NCT06379516Not specifiedCOMPLETEDProcess Validation in Dermatology: Assessing Wound Creation Methods and Treatment Efficacy
NCT06640036Not specifiedCOMPLETEDFILIP: Fat Intake, Inflammation and LIPids

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.